Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6

Hormones & Cancer
Hirofumi AndoTanri Shiozawa

Abstract

Although progestin has been used to treat endometrial hyperplasia and endometrial carcinoma (EC), its therapeutic efficacy is limited. In order to improve this, the underlining mechanisms of the effects of progestin need to be elucidated in more detail. In the present study, we examined the involvement of mitogen-inducible gene-6 (MIG6), a negative regulator of the EGF receptor, in the progestin-mediated growth suppression of endometrial epithelia. The immunohistochemical expression of MIG6 was elevated in the early to mid-secretory phases of normal endometrium and also with endometrial hyperplasia after medroxyprogesterone acetate (MPA) therapy. The addition of progesterone (P4) to progesterone receptor (PR)-positive EC cells reduced the viability and induced MIG6 messenger RNA (mRNA) and protein expression. The silencing of MIG6 using siRNA eliminated the P4-mediated reduction of EC cell viability, indicating that MIG6 is an essential downstream component of PR-mediated growth suppression. In order to enhance PR-driven signals, we examined the effects of histone deacetylase (HDAC) inhibitors because histone acetylation has been shown to increase the expression of PR. The addition of three HDAC inhibitors (panobinostat, LBH589...Continue Reading

References

Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimio UshijimaToshiharu Kamura
May 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jae-Wook JeongFrancesco J DeMayo
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Haoqiang YingRonald A DePinho
Dec 7, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Satoru KyoMasaki Inoue
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Mar 1, 2011·Trends in Endocrinology and Metabolism : TEM·Shujie YangKimberly K Leslie
Jul 31, 2013·Current Pharmaceutical Design·Shujie YangKimberly K Leslie
Jan 6, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Ali Dastranj TabriziSanam Bidadi
Feb 1, 2015·Japanese Journal of Clinical Oncology·Kota KatanodaHiroshi Nishimoto
May 8, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Stanislav Mikhailovich ProninElena Grigorievna Novikova
Jun 26, 2015·World Journal of Surgical Oncology·Yanli ZhangJing Sun
Sep 18, 2015·Population Health Metrics·John Bongaarts, Ann K Blanc
Feb 5, 2016·Contemporary Oncology Współczesna Onkologia·Karolina GołąbekMarek Michalski
May 31, 2016·Bioorganic Chemistry·Mohammed ManalM J Nanjan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.